Cosmetic method
US-2021338568-A1 · Nov 4, 2021 · US
Use of gingival fibroblasts in the treatment of alopecia
US10624838B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10624838-B2 |
| Application number | US-201414904151-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 9, 2014 |
| Priority date | Jul 9, 2013 |
| Publication date | Apr 21, 2020 |
| Grant date | Apr 21, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to the use of gingival fibroblast-derived products to reduce hair loss and promote hair growth. Specifically, the invention relates to a product derived from gingival fibroblasts to be used in the treatment or prevention of alopecia, as well as in the promotion of natural hair growth and/or in the control of natural hair loss.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for limiting hair/body hair loss and/or promoting the growth of hair/body hair and/or increasing the density of hair follicles in an individual, comprising administering an effective quantity of a gingival fibroblast-derived product to the individual to limit hair/body hair loss and/or to promote the growth of hair/body hair and/or to increase the density of hair follicles in the individual. 2. The method according to claim 1 , wherein the hair loss and/or hair growth and/or density of hair follicles are natural. 3. The method according to claim 1 , wherein the gingival fibroblast-derived product is selected from the group consisting of gingival fibroblasts, gingival fibroblasts from a culture, a gingival fibroblast extract and a gingival fibroblast conditioned medium. 4. The method according to claim 1 , wherein the gingival fibroblast is heterologous, autologous or allogeneic. 5. The method according to claim 1 , wherein the gingival fibroblast-derived product is administered in association with at least one anti-hair loss agent. 6. The method according to claim 1 , wherein the gingival fibroblast-derived product is administered in association with at least one anti-hair loss agent selected from the group consisting of finasteride and minoxidil.
Assignees
Inventors
Classifications
Preparations for affecting hair growth · CPC title
- A61K8/981Primary
of mammals or bird · CPC title
containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048}) · CPC title
Chemical, physico-chemical or functional or structural properties of particular ingredients · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10624838B2 cover?
- The present invention relates to the use of gingival fibroblast-derived products to reduce hair loss and promote hair growth. Specifically, the invention relates to a product derived from gingival fibroblasts to be used in the treatment or prevention of alopecia, as well as in the promotion of natural hair growth and/or in the control of natural hair loss.
- Who is the assignee on this patent?
- Assist Publique—Hopitaux De Paris, Inst Nat Sante Rech Med, Inst De Radioprotection Et De Surete Nucleaire, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K8/981. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).